ムンプス分子診断 - 再燃の緩和、南インドの報告
N Ashokumar1, K Jaya Swathi2, Senthilraja Ramalingam2
1Molecular Biologist, Department of Molecular Biology, Microbiological Laboratory, Deralakatta, Mangalore, India.
Summary:
Mumps infection, a public health problem caused by the mumps virus, presents with uni/bilateral swelling of the parotid gland(s) with meningitis and orchitis as complications. The COVID-19 pandemic disrupted successful mumps vaccination programs. A prospective study was conducted from January to March 2024 to diagnose suspected mumps patients attending hospitals in southern India. Samples analyzed for mumps using fast-track diagnostics reverse transcription polymerase chain reaction kits were categorized as per WHO clinical case definition. Of 200 samples screened, 26 (13%) were positive - 10 blood, 11 cerebrospinal fluid, and 5 Buccal swab samples. In developing countries like India, laboratories with advanced testing methodologies reduce mumps-related morbidity.


